Protein kinases are highly evolved signal transduction enzymes that regulate almost every biological process known. As members of the largest gene family in the human genome, understanding the cellular role of each protein kinase will greatly improve our ability to selectively perturb cell signaling to treat diseases such as cancer. In the last 3-5 years, the description of interaction maps of entire organisms such as Saccharomyces cerevisiae, have provided a system wide """"""""snapshot"""""""" of all protein protein interactions in a cell. Protein kinases have been identified in such nodes and as key components of all aspects of the interaction map. Yet, interaction maps do not address the fundamental action of each protein kinase (i.e. which substrates are phosphorylated by which kinase in the cell.) Chemical genetic tools for analysis of the direct substrates of any protein kinase in the genome have successfully identified novel downstream substrates of v-Src, CDC28, JNK, CDK2 and others. The substrate tracing approach relies on an engineered kinase, which can uniquely accept an [y-32P] ATP analog ([y-32P] A*TP). Direct substrates of the kinase of interest are identified by standard protein chromatography and analysis for 32P containing proteins. The drawback of this approach has been the difficulty in isolation of low abundance substrates or substrates phosphorylated at low stoichiometry. The vast majority of kinase substrates fall into this category, since they represent regulators of critical molecular machines, which drive the cell cycle, chromosome segregation, etc., rather than typical """"""""house-keeping"""""""" proteins, which are often abundant. To overcome this limitation, a new method for identification of low abundance phosphoproteins is proposed. The new method relies on development of a new ATP analog capable of delivering an affinity tag to the direct substrates of any kinase. The affinity tag will function like biotin, in that it can be used as a handle to purify proteins away from irrelevant non-kinase substrate related proteins. The complete repertoire of substrates phosphorylated by the mammalian mitotic kinase CDC2/cyclin B will be analyzed by this method in order to address the fundamental role of this key kinase in driving the mitotic component of the mammalian cell cycle. These targets will provide new avenues for targeted cancer therapy. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
9R01EB001987-09
Application #
6686922
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Kelley, Christine A
Project Start
1996-05-01
Project End
2008-04-30
Budget Start
2003-05-15
Budget End
2004-04-30
Support Year
9
Fiscal Year
2003
Total Cost
$352,667
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ultanir, Sila K; Yadav, Smita; Hertz, Nicholas T et al. (2014) MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development. Neuron 84:968-82
Riel-Mehan, Megan M; Shokat, Kevan M (2014) A crosslinker based on a tethered electrophile for mapping kinase-substrate networks. Chem Biol 21:585-90
Ducker, G S; Atreya, C E; Simko, J P et al. (2014) Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene 33:1590-600
Tan, Ying Xim; Manz, Boryana N; Freedman, Tanya S et al. (2014) Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling. Nat Immunol 15:186-94
Warkentin, Alexander A; Lopez, Michael S; Lasater, Elisabeth A et al. (2014) Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy. Elife 3:
Zhang, Chao; Lopez, Michael S; Dar, Arvin C et al. (2013) Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology. ACS Chem Biol 8:1931-8
Kaasik, Krista; Kivimäe, Saul; Allen, Jasmina J et al. (2013) Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab 17:291-302
Lopez, Michael S; Choy, Jonathan W; Peters, Ulf et al. (2013) Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technology. J Am Chem Soc 135:18153-9
Schachter, Miriam Merzel; Merrick, Karl A; Larochelle, Stephane et al. (2013) A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression. Mol Cell 50:250-60
Hertz, Nicholas T; Berthet, Amandine; Sos, Martin L et al. (2013) A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1. Cell 154:737-47

Showing the most recent 10 out of 55 publications